{"id":13270,"date":"2026-05-22T12:26:34","date_gmt":"2026-05-22T10:26:34","guid":{"rendered":"https:\/\/orsingher.com\/?p=13270"},"modified":"2026-05-31T12:28:39","modified_gmt":"2026-05-31T10:28:39","slug":"orsingher-ortu-avvocati-associati-at-the-eu-pharmaceutical-law-forum-in-brussels","status":"publish","type":"post","link":"https:\/\/orsingher.com\/en\/orsingher-ortu-avvocati-associati-at-the-eu-pharmaceutical-law-forum-in-brussels\/","title":{"rendered":"Orsingher Ortu &#8211; Avvocati Associati at the EU Pharmaceutical Law Forum in Brussels"},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Stefano Giberti and Francesco Setti attended the EU Pharmaceutical Law Forum (19\u201321 May, Brussels), one of Europe&#8217;s leading events for pharma law practitioners.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">Over three days, sessions covered the most pressing issues in the sector: antitrust, patents and supplementary protection certificates, commercial transactions, data privacy and regulatory frameworks. The programme featured contributions from the European Commission, the EMA and key competition authorities.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\">A valuable opportunity to gain insight into the latest developments across one of the most dynamic and complex areas of European law, and to strengthen relationships with leading international players in the pharmaceutical industry.<\/p>\n<div style=\"width: 1080px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-13270-1\" width=\"1080\" height=\"1080\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/orsingher.com\/wp-content\/uploads\/2026\/05\/EU-Pharmaceutical-Law-Forum-1.mp4?_=1\" \/><a href=\"https:\/\/orsingher.com\/wp-content\/uploads\/2026\/05\/EU-Pharmaceutical-Law-Forum-1.mp4\">https:\/\/orsingher.com\/wp-content\/uploads\/2026\/05\/EU-Pharmaceutical-Law-Forum-1.mp4<\/a><\/video><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Stefano Giberti and Francesco Setti attended the EU Pharmaceutical Law Forum (19\u201321 May, Brussels), one of Europe&#8217;s leading events for pharma law practitioners. Over three days, sessions covered the most pressing issues in the sector: antitrust, patents and supplementary protection certificates, commercial transactions, data privacy and regulatory frameworks. The programme featured contributions from the European [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[63],"tags":[],"class_list":["post-13270","post","type-post","status-publish","format-standard","hentry","category-news-en-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/13270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/comments?post=13270"}],"version-history":[{"count":0,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/13270\/revisions"}],"wp:attachment":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/media?parent=13270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/categories?post=13270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/tags?post=13270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}